Australia markets close in 3 hours 47 minutes

Sanofi (SNYNF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
101.580.00 (0.00%)
At close: 12:05PM EDT
Full screen
Loading interactive chart…
  • Financial Times

    Unilever and Sanofi pile on pressure over 2035 EU petrol ban

    A cross-sector coalition of companies including Unilever, Zurich, Sanofi and Uber have urged the EU to ban the sale of new petrol and diesel vehicles from 2035, piling pressure on the auto industry ahead of a crunch vote. In a public letter to be sent to MEPs and ministers on Tuesday, the group says such a decision would “set in motion an urgently needed systemic transformation and make Europe a global leader in a key industry”. Volkswagen’s chief executive Herbert Diess has also directly criticised German utility companies in the past, including coal-fired power producers RWE and Uniper, for not doing enough to decarbonise energy.

  • GlobeNewswire

    Press Release: Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy

    Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy Latest results of the Phase 3 IKEMA trial demonstrate the longest median progression free survival (mPFS) on a proteasome inhibitor backbone in patients who relapsed after a prior therapy, including lenalidomideThe median progression free survival, increased from 19.2 months to 35.7 months when Sarclisa was added to carfilz

  • Zacks

    Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug

    The FDA accepts Regulus' (RGLS) IND application for RGLS8429 to treat autosomal dominant polycystic kidney disease. The company plans to begin a phase I study in second-quarter 2022. Stock up.